SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001267602-22-000007
Filing Date
2022-02-28
Accepted
2022-02-25 18:17:08
Documents
12
Period of Report
2022-02-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K alim-20220222x8k.htm   iXBRL 8-K 61408
  Complete submission text file 0001267602-22-000007.txt   186388

Data Files

Seq Description Document Type Size
2 EX-101.SCH alim-20220222.xsd EX-101.SCH 2340
3 EX-101.LAB alim-20220222_lab.xml EX-101.LAB 19882
4 EX-101.PRE alim-20220222_pre.xml EX-101.PRE 11130
6 EXTRACTED XBRL INSTANCE DOCUMENT alim-20220222x8k_htm.xml XML 4815
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 22682891
SIC: 2834 Pharmaceutical Preparations